![Michael Weiss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Weiss
Directeur Général chez
TG THERAPEUTICS, INC.
Fortune : 377 M $ au 31/05/2026
Profil
M. Michael S. Weiss est président du conseil d'administration de Checkpoint Therapeutics, Inc. et président exécutif de Mustang Bio, Inc. et associé d'Opus Point Partners Management LLC, associé et gestionnaire de portefeuille d'Opus Point Partners LLC et président exécutif, président et PDG de TG Therapeutics, Inc. Il siège au conseil d'administration de Cyprium Therapeutics, Inc, Fortress Biotech, Inc, Caelum Biosciences, Inc, Cellvation, Inc et Helocyte, Inc. M. Weiss a été précédemment employé en tant que président du conseil d'administration de National Holdings Corp, directeur non exécutif d'Avenue Therapeutics, Inc. et coprésident de CB Pharma Acquisition Corp, président exécutif de IASO Pharma, Inc. et président non exécutif de National Holdings Corp, président de XTL Biopharmaceuticals Ltd, président et directeur général de Keryx Biopharmaceuticals, Inc, président et directeur général d'ACCESS Oncology, Inc, président de Paligent, Inc, administrateur de Cancer Care, Inc, et avocat de Cravath, Swaine & Moore LLP. Il a également été membre du conseil d'administration de Healthcare Integrated Services, Inc. et de Genta, Inc. Il a obtenu son diplôme de premier cycle à l'Université d'État de New York à Albany et un diplôme de deuxième cycle à la Columbia Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TG THERAPEUTICS, INC. 6,39 % | 14/04/2026 | 9 778 086 ( 6,39 % ) | 371 M $ | 31/05/2026 |
FORTRESS BIOTECH, INC. 6,85 % | 16/04/2026 | 2 276 562 ( 6,85 % ) | 6 M $ | 31/05/2026 |
| 18/11/2025 | 325 ( 0 % ) | 218 $ | 31/05/2026 |
Postes actifs de Michael Weiss
| Sociétés | Poste | Début |
|---|---|---|
| TG THERAPEUTICS, INC. | Directeur Général | 29/12/2011 |
| FORTRESS BIOTECH, INC. | Directeur/Membre du Conseil | 20/12/2013 |
| MUSTANG BIO, INC. | Président | 01/05/2015 |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of Menkes disease and related copper metabolism disorders | Fondateur | 01/01/2017 |
Cellvation, Inc.
 Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Directeur/Membre du Conseil | - |
Helocyte, Inc.
 Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Directeur/Membre du Conseil | - |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for treatment of central nervous system disorders | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Weiss
| Sociétés | Poste | Fin |
|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Directeur Général | 01/12/2016 |
| AVENUE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/02/2019 |
| ░░░░ ░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Michael Weiss
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
39
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
Paligent, Inc.
 Paligent, Inc. Financial ConglomeratesFinance Development stage company | Finance |
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
National Holdings Corp.
 National Holdings Corp. Investment Banks/BrokersFinance Operates as a holding company whose subsidiaries provides securities brokerage services | Finance |
Healthcare Integrated Services, Inc.
 Healthcare Integrated Services, Inc. Medical/Nursing ServicesHealth Services Operates fixed-site magnetic resonance imaging centers | Health Services |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Health Technology |
Genta, Inc.
 Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Health Technology |
IASO Pharma, Inc.
 IASO Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products | Health Technology |
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
XTL Biopharmaceuticals Ltd.
 XTL Biopharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops pharmaceutical drugs for the treatment of autoimmune diseases | Health Technology |
Cravath, Swaine & Moore LLP
 Cravath, Swaine & Moore LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
State University of New York at Albany
 State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cancer Care, Inc.
 Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance OPPM invests in and assists biotechnology and healthcare companies in developing and commercializing novel medicines and diagnostic tools. | Finance |
Columbia Law School
 Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Origo Acquisition Corp.
 Origo Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Checkpoint Therapeutics, Inc.
 Checkpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Opus Point Partners LLC
 Opus Point Partners LLC Financial ConglomeratesFinance Provides investment services | Finance |
Avenue Therapeutics, Inc.
 Avenue Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases | Health Technology |
Helocyte, Inc.
Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Health Technology |
Mustang Bio, Inc.
 Mustang Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops novel immunotherapy''s | Health Technology |
Cyprium Therapeutics, Inc.
Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of Menkes disease and related copper metabolism disorders | Health Technology |
Cellvation, Inc.
Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Health Technology |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that develops treatments for AL amyloidosis, rare and life-threatening hematologic disorders | Health Technology |
Baergic Bio, Inc.
Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for treatment of central nervous system disorders | Health Technology |
